Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)
China
· Delayed Price · Currency is CNY 15.65
-0.45 (-2.80%)
At close: Jul 4, 2025, 2:57 PM CST
SHE:301246 Market Cap
SHE:301246 has a market cap or net worth of 6.21 billion as of July 3, 2025. Its market cap has increased by 12.04% in one year.
Market Cap
6.21B
Enterprise Value
5.07B
Revenue
1.78B
Ranking
n/a
PE Ratio
213.57
Stock Price
15.65
Market Cap Chart
Since March 20, 2023, SHE:301246's market cap has decreased from 16.78B to 6.21B, a decrease of -62.99%. That is a compound annual growth rate of -35.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 4, 2025 | 6.21B | 15.32% |
| Dec 31, 2024 | 5.39B | -48.18% |
| Dec 29, 2023 | 10.39B | -38.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 346.15B |
| Shenzhen Mindray Bio-Medical Electronics | 272.10B |
| WuXi AppTec | 200.95B |
| Zhangzhou Pientzehuang Pharmaceutical., | 120.06B |
| Sichuan Biokin Pharmaceutical | 117.46B |
| Aier Eye Hospital Group | 114.52B |
| Shanghai United Imaging Healthcare | 103.45B |
| Yunnan Baiyao Group Co.,Ltd | 99.17B |